Intrinsic Value of S&P & Nasdaq Contact Us

Verastem, Inc. VSTM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.00
+160.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Verastem, Inc. (VSTM) has a negative trailing P/E of -2.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 32.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -46.60%, forward earnings yield 3.12%. PEG 0.08 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.08); analyst target implies upside (+160.6%).
  • Forward P/E 32.0 — analysts expect a return to profitability with estimated EPS of $0.19 for FY2029.
  • PEG Ratio 0.08 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -46.60% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 3.12% as earnings recover.
  • Analyst consensus target $16.00 (+160.6% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
48/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — VSTM

Valuation Multiples
P/E (TTM)-2.1
Forward P/E32.0
PEG Ratio0.08
Forward PEG0.08
P/B Ratio7.86
P/S Ratio12.09
EV/EBITDA-1.2
Per Share Data
EPS (TTM)$-2.51
Forward EPS (Est.)$0.19
Book Value / Share$0.69
Revenue / Share$0.37
FCF / Share$-1.65
Yields & Fair Value
Earnings Yield-46.60%
Forward Earnings Yield3.12%
Dividend Yield0.00%
Analyst Target$16.00 (+160.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -1.1 0.03 0.57 0.00 -
2017 -1.7 -0.02 2.04 0.00 -
2018 -3.2 0.08 1.87 8.72 -
2019 -0.7 -0.01 13.93 5.72 -
2020 -4.8 0.06 2.83 3.69 -
2021 -5.0 0.74 4.08 174.15 -
2022 -1.0 0.15 1.63 29.84 -
2023 -2.1 0.15 3.13 0.00 -
2024 -1.4 0.19 -6.39 18.46 -
2025 -2.6 0.15 9.35 17.31 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-11.82 $0.00 $-36.44M -
2017 $-21.18 $0.00 $-67.8M -
2018 $-12.54 $26.72M $-72.43M -271.1%
2019 $-27.22 $17.46M $-169.18M -969.2%
2020 $-5.30 $88.52M $-67.73M -76.5%
2021 $-5.58 $2.05M $-81.1M -3950.3%
2022 $-4.58 $2.6M $-73.85M -2844.7%
2023 $-3.96 $0.00 $-87.37M -
2024 $-3.66 $10M $-130.64M -1306.4%
2025 $-3.02 $30.91M $-209.47M -677.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.64 $-1.92 – $-1.31 $117.27M $110.8M – $123.73M 4
2027 $-0.72 $-0.85 – $-0.63 $201.72M $183.51M – $231.21M 3
2028 $-0.45 $-0.98 – $-0.06 $301.77M $296.9M – $306.65M 6
2029 $0.19 $0.17 – $0.23 $444.45M $404.33M – $509.42M 4
2030 $0.97 $0.86 – $1.16 $597.3M $543.39M – $684.62M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message